
STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network
Keywords: کیناز جانوس ; AE; adverse event; AKT; acutely transforming retrovirus AKT8 in rodent T-cell lymphoma; CI; confidence interval; CR; complete response; GIST; gastrointestinal stromal tumors; JAK; Janus kinase; MAPK; mitogen-activated protein kinase; OS; overall survival;